Table 2.
Peptides of SARS-CoV-2.
| Peptide | Sequence | aa |
|---|---|---|
| M01 | MADSNGTITVEELKKLLEQW | 1–20 |
| M02 | EELKKLLEQWNLVIGFLFLT | 11–30 |
| M03 | NLVIGFLFLTWICLLQFAYA | 21–40 |
| M04 | WICLLQFAYANRNRFLYIIK | 31–50 |
| M05 | NRNRFLYIIKLIFLWLLWPV | 41–60 |
| M06 | LIFLWLLWPVTLACFVLAAV | 51–70 |
| M07 | TLACFVLAAVYRINWITGGI | 61–80 |
| M08 | YRINWITGGIAIAMACLVGL | 71–90 |
| M09 | AIAMACLVGLMWLSYFIASF | 81–100 |
| M10 | MWLSYFIASFRLFARTRSMW | 91–110 |
| M11 | RLFARTRSMWSFNPETNILL | 101–120 |
| M12 | SFNPETNILLNVPLHGTILT | 111–130 |
| M13 | NVPLHGTILTRPLLESELVI | 121–140 |
| M14 | RPLLESELVIGAVILRGHLR | 131–150 |
| M15 | GAVILRGHLRIAGHHLGRCD | 141–160 |
| M16 | IAGHHLGRCDIKDLPKEITV | 151–170 |
| M17 | IKDLPKEITVATSRTLSYYK | 161–180 |
| M18 | ATSRTLSYYKLGASQRVAGD | 171–190 |
| M19 | LGASQRVAGDSGFAAYSRYR | 181–200 |
| M20 | SGFAAYSRYRIGNYKLNTDH | 191–210 |
| M21 | IGNYKLNTDHSSSSDNIALLVQ | 201–222 |
| S | TESNKKFLPFQQFGRDIA | 553–570 |
| N | NNAAIVLQLPQGTTLPKG | 153–170 |